Mark Anderson, M.D., Ph.D., University of California - San Francisco (IMAGE)
Caption
The researchers, led by immunologist Mark Anderson, M.D., Ph.D., a professor with the UCSF Diabetes Center, have discovered a distinctive type of immune cell called an eTAC, which puts a damper on immune responses.
Credit
UCSF
Usage Restrictions
Credit Required
License
Licensed content